Streetbeat News

Regulatory

ARKK

COIN

Ethereum co-founder Vitalik Buterin advises against choosing political allegiances based solely on pro-crypto stances. He warns that politicians who appear pro-crypto today might not be in the future and emphasizes the importance of foundational freedoms over cryptocurrency support. This comes as more business and crypto figures, including the Winklevoss twins, donate to Trump's campaign due to his pro-crypto stance.

Portfolio Pulse from Chris Katje

July 17, 2024 | 8:19 pm

AMRN

The Portuguese Ministry of Health has approved VAZKEPA for national reimbursement to reduce cardiovascular risk in high-risk patients. This marks the eighth national reimbursement in Europe. Amarin will begin commercialization in Portugal on August 1, 2024.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2024 | 8:18 pm

CI

DIA

DYLG

ELV

IHF

IYH

UNH

XLV

Healthcare investors are anticipating that a potential Trump administration could ease regulations on Medicare Advantage, which may benefit health insurers like UnitedHealth, Cigna, and Humana. This expectation has led to mixed results in the health insurance sector, with some stocks rising and others falling. ETFs holding health insurer stocks have generally trended upward.

Portfolio Pulse from Michael Juliano

July 17, 2024 | 8:09 pm

RARE

Ultragenyx has reached an agreement with the FDA on the endpoints for its Phase 3 study of GTX-102. The Phase 3 study is set to begin by the end of the year, following a successful end-of-Phase 2 meeting. The study will be a global double-blind sham-controlled pivotal study, with an additional study planned for patients with other mutations.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2024 | 8:06 pm

PFE

VALN

Pfizer Inc. and Valneva SE announced the completion of the primary vaccination series in their Phase 3 VALOR Lyme Disease trial. Participants received three doses of the VLA15 vaccine and will be monitored until the end of the Lyme disease season in 2025.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2024 | 8:02 pm

CHUY

Trading for CHUY was halted at 4:00:10 p.m. ET due to pending news.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2024 | 8:00 pm

META

VGK

Meta will not offer its future multimodal AI models in the EU due to regulatory uncertainties. This decision highlights growing tensions between U.S. tech giants and European regulators. Meta's move could impact European companies and consumers, as well as the competitiveness of European firms.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2024 | 7:59 pm

BLK

BTCUSD

Venture capitalist Luke Martin describes Bitcoin as a 'liquidity and attention black hole,' highlighting its growing influence in finance and politics. Bitcoin's impact is evident in the recent presidential election and the success of Bitcoin ETFs. Google Trends data shows increasing interest in Bitcoin, correlating with recent market movements.

Portfolio Pulse from Khyathi Dalal

July 17, 2024 | 7:23 pm

APLM

Apollomics Inc (NASDAQ:APLM) shares surged by 17.6% to $0.24 after receiving a 180-day extension from Nasdaq to address non-compliance with listing requirements. The company must achieve a minimum bid price of $1.00 per share for ten consecutive business days by January 13, 2025, to avoid delisting.

Portfolio Pulse from Henry Khederian

July 17, 2024 | 7:20 pm

SPY

USO

The Biden administration privately warned Iran about suspicious nuclear activities, raising concerns about potential nuclear weapon development. U.S. and Israeli intelligence detected these activities, but Iran denied any policy change. The situation led to increased security for former President Trump due to an unrelated Iranian assassination plot. Despite some easing of anxieties, significant concerns remain about Iran's nuclear ambitions.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2024 | 7:19 pm